comparemela.com

Professor Of Surgery Medical University Vienna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Paragonix SherpaPak Cardiac Transport System Heart Transplant and Improved 1-Year Mortality

Investigators have found that patients who receive a heart transplant with the SherpaPak Cardiac Transport System have better 1-year outcomes.

United statesMarzia leaccheParagonix sherpapakAndreas zuckermannProfessor of surgery medical university viennaSpectrum healthParagonix sherpapak cardiac transport systemGlobal utilization and registry databaseCardiac transplantationAssociate professorSurgery medical universityHeart registryPost transplant mechanically circulatory supportSurvival analysisRichard devos endowed chairHeart transplant

Paragonix Technologies SherpaPak Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition to improvement in 1-year survival

United statesMarzia leaccheDavid dalessandroLisa andersonAndreas zuckermannProfessor of surgery medical university viennaMeeting of the international society for heartUs multi centerSpectrum healthParagonix technologies incParagonix technologiesParagonix sherpapak cardiac transport systemInternational societyLung transplantationHeart registryTransplant survival analysis

vimarsana © 2020. All Rights Reserved.